To investors and prospective investors:

We were founded in 2019 and made our first investment into a small biotech company. Our investments may include preferred stock, common stock, stock warrants, stock options, convertible notes, private equity positions or other investment forms.

Ryan Shay and Brent Orr each invested in our initial investment in a biotech company multiple years ago, neither having any idea that the other had invested. Upon learning that each had invested, the joint brain storming began. We began to consider how we might be able to create value for Cool Blue Capital, the Company and potential partners.

With the help of Johnson & Jones, attorneys at law, we began the process of researching the best way to reach our goals and objectives.

We have since made investments in other opportunities and have been joined by many other partners in those ventures as well.